{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:09:14Z","timestamp":1761516554344,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.4158\/ep-2018-0154","type":"journal-article","created":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T12:43:42Z","timestamp":1530794622000},"page":"875-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differential Regulation of 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Activity in Patients with Differing Etiologies of Hypopituitarism"],"prefix":"10.1016","volume":"24","author":[{"given":"Amar","family":"Agha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy Ann","family":"Behan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Forde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman F.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diarmuid","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Monson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2018-0154_bb0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/beem.2000.0119","article-title":"Cortisol metabolism and the role of 11\u03b2-hydroxysteroid dehydrogenase","volume":"15","author":"Tomlinson","year":"2001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0154_bb0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000115363","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 and obesity","volume":"36","author":"Morton","year":"2008","journal-title":"Front Horm Res"},{"key":"10.4158\/EP-2018-0154_bb0020","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.2337\/db08-0495","article-title":"Impaired glucose tolerance and insulin resistance are associated with increased adipose 11\u03b2-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5\u03b1-reductase activity","volume":"57","author":"Tomlinson","year":"2008","journal-title":"Diabetes"},{"key":"10.4158\/EP-2018-0154_bb0025","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.onc.1206293","article-title":"Abnormal expression of 11\u03b2-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation","volume":"22","author":"Rabbitt","year":"2003","journal-title":"Oncogene"},{"key":"10.4158\/EP-2018-0154_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","article-title":"Clinical aspects of growth hormone deficiency in adults","volume":"16","author":"de Boer","year":"1995","journal-title":"Endocr Rev"},{"key":"10.4158\/EP-2018-0154_bb0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2265.2007.02763.x","article-title":"Modulation of glucocorticoid metabolism by the growth hormone\u2013IGF-1 axis","volume":"66","author":"Agha","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0154_bb0040","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2005-1694","article-title":"Growth hormone (GH) substitution in GH-deficient patients inhibits 11\u03b2-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue","volume":"91","author":"Paulsen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0154_bb0045","first-page":"4172","article-title":"Modulation of 11\u03b2-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies","volume":"84","author":"Moore","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0154_bb0050","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2265.1994.tb01830.x","article-title":"The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults","volume":"41","author":"Weaver","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0154_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2265.1998.3641180.x","article-title":"The effect of growth hormone replacement therapy on cortisol\u2013cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11\u03b2-hydroxysteroid dehydrogenase activity","volume":"48","author":"Gelding","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0154_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/EJE-13-0596","article-title":"Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients","volume":"170","author":"Behan","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0154_bb0065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2265.2011.04074.x","article-title":"Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients","volume":"75","author":"Behan","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.4158\/EP-2018-0154_bb0070","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1530\/EJE-15-1187","article-title":"Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients","volume":"174","author":"Behan","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP-2018-0154_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/jc.2003-030442","article-title":"Features of the metabolic syndrome after childhood craniopharyngioma","volume":"89","author":"Srinivasan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0154_bb0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1365-2265.2010.03838.x","article-title":"Morbidity and mortality in patients with craniopharyngioma after surgery","volume":"73","author":"Crowley","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP-2018-0154_bb0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12020-016-1196-y","article-title":"Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma","volume":"58","author":"Ferra\u00f9","year":"2017","journal-title":"Endocrine"},{"key":"10.4158\/EP-2018-0154_bb0090","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1210\/jc.2005-0185","volume":"90","author":"Verhelst","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0154_bb0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40618-014-0196-0","article-title":"Analysis of short-and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma","volume":"38","author":"Profka","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP-2018-0154_bb0100","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2009-0766","article-title":"Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome","volume":"94","author":"Barahona","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0154_bb0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2265.2003.01894.x","article-title":"The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement","volume":"59","author":"Swords","year":"2003","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20354525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20354525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:04:05Z","timestamp":1761516245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20354525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1530891X20354525"],"URL":"https:\/\/doi.org\/10.4158\/ep-2018-0154","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Regulation of 11\u03b2-Hydroxysteroid Dehydrogenase Type 1 Activity in Patients with Differing Etiologies of Hypopituitarism","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2018-0154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}